Gluten News and Research

RSS

Insight into how coeliac disease is triggered

For the first time, scientists have visualised an interaction between gluten and T-cells of the immune system, providing insight into how coeliac disease, which affects approximately 1 in 133 people, is triggered.

12 Oct 2012

Nottingham expert to study impact of gluten intolerance on patients in the UK

A University of Nottingham expert has been awarded -80,000 by two national charities to study the impact of gluten intolerance on patients in the UK.

27 Sep 2012

Warning signs of eating disorders in children

It's a discussion that strikes fear in the hearts of most parents – adolescents expressing concern about their weight. According to statistics, 1 out of every 100 girls, between the ages of 10 and 20, struggles with anorexia and four percent of college-aged women have bulimia. So how can parents distinguish between normal adolescent insecurities and the start of a dangerous eating disorder?

19 Sep 2012

Data from BioLineRx’s BL-7010 pre-clinical studies on celiac disease

BioLineRx, a biopharmaceutical development company, announced today that BL-7010, an orally available treatment for celiac disease, was found to be safe and well tolerated in pre-clinical studies conducted to date.

10 Sep 2012

Researchers identify genetic variations linked with onset of Barrett's oesophagus

Genetic variations that are linked with the onset of Barrett's oesophagus (BE), a pre-cancerous condition of the lower end of the gullet, have been identified for the first time. The discovery of variations in regions on two chromosomes makes it possible to develop screening tests for people at high risk of developing the disease.

10 Sep 2012

ImmusanT commences Nexvax2 clinical trials for celiac disease in New Zealand, Australia and the U.S.

ImmusanT announced today that it has initiated clinical trials in New Zealand, Australia and the U.S. to evaluate Nexvax2, the first therapeutic vaccine for patients with celiac disease. Nexvax2 is designed to re-establish patients' tolerance to the toxic effects of gluten, a protein in wheat, barley and rye, and allow them to return to a normal diet.

5 Sep 2012

Medicine brand choices: an interview with Dr Lynn Weekes

In Australia, people will only be offered a choice when the brands are bioequivalent, meaning they contain the same active ingredient (i.e. the chemical in the medicine that makes it work) and have been proven to work the same in the body.

15 Aug 2012

Allergy alerts in patient records help improve clinical practice

Allergy alerts in patient records have the potential to significantly improve clinical practice, say Spanish researchers.

3 Aug 2012

Around 1.4 million of Americans with celiac disease are unaware of it

Roughly 1.8 million Americans have celiac disease, but around 1.4 million of them are unaware that they have it, a Mayo Clinic-led analysis of the condition's prevalence has found.

1 Aug 2012

Follow-up exams for patients with celiac disease are often inadequate and highly variable

Follow-up exams for patients with celiac disease are often inadequate and highly variable, according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association (AGA).

26 Jul 2012

Allergy to deamidated gluten a separate phenotype to wheat allergy

Severe allergic reactions to deamidated gluten in individuals tolerant to wheat are linked to a separate phenotype of wheat allergy, suggest study findings.

20 Jul 2012

UPM researchers develop a functional biscuit for celiac patients

Researchers at the Universidad Politécnica de Madrid (UPM) have patented a biscuit which is made from teff flour, suitable for celiac patients, and, thanks to its nutritional properties, it is ideal for sportsmen, diabetics and people with anemia.

4 Jul 2012

Gluten-free diet may not be a good choice for everyone

One of the latest trends in the food market and among celebrities is going gluten-free. Snack giant Frito-Lay has announced it will introduce new gluten-free labels and products, and Miley Cyrus has credited her recent weight loss to a gluten-free diet.

29 Jun 2012

Benefits of green banana flour-based pasta for people with celiac disease

People with celiac disease struggle with limited food choices, as their condition makes them unable to tolerate gluten, found in wheat and other grains. Researchers from the University of Brazil have developed a gluten-free pasta product from green banana flour, which tasters found more acceptable than regular whole wheat pasta.

23 Jun 2012

Patients taking common blood pressure drug show symptoms of celiac disease

Mayo Clinic researchers have discovered an association between a commonly prescribed blood pressure drug, Olmesartan, and severe gastrointestinal issues such as nausea, vomiting, diarrhea, weight loss and electrolyte abnormalities -- symptoms common among those who have celiac disease. The findings are published online today in the medical journal Mayo Clinic Proceedings.

22 Jun 2012

Link between Olmesartan drug and severe GI issues

22 Jun 2012

Report: Autoimmune diseases are all being diagnosed at rapid rates

There is a disturbing trend in autoimmune disease diagnosis; many are on the upswing. Recent reports show that type 1 diabetes (an autoimmune disease not related to obesity), celiac disease and lupus, among others autoimmune diseases, are all being diagnosed at rapid rates.

22 Jun 2012

Pioneering new test can quickly diagnose coeliac disease

Coeliac disease affects millions of people worldwide, but many sufferers are not aware they have the condition or may have been misdiagnosed with other illnesses. A pioneering new test developed with EU-funding should soon be available in hospitals, offering an accurate, quick, cost-effective diagnosis and monitoring solution.

6 Jun 2012

Walnuts make a nutritious snack

Ninety percent of American adults snack daily and could be gaining valuable nutrition. A paper published in the British Journal of Nutrition found that smaller nutritious meals eaten throughout the day contribute significantly to the nutrient quality of the diet. The key is making snacking choices that are not "empty calories" but healthful options, providing important vitamins and minerals.

2 Jun 2012

Data from Alvine’s ALV003 Phase 2A trial on celiac disease presented at DDW 2012

Alvine Pharmaceuticals, Inc. today announced the presentation of data from a Phase 2A trial of its lead compound, ALV003, at the 2012 Digestive Diseases Week (DDW) meeting held in San Diego, California. The study results met the primary endpoint of demonstrating that oral ALV003, administered in the context of a gluten free diet (GFD), can diminish gluten-induced intestinal mucosal injury in well-controlled celiac disease patients. The company plans to initiate a Phase 2B trial later this year.

23 May 2012